Imaging AI in Washington

EchoNous is a medical technology company specializing in AI-powered, ultraportable point-of-care ultrasound (POCUS) systems that enhance bedside diagnostics across clinical settings. Founded in 2016 and headquartered in Redmond, Washington, the company integrates advanced ultrasound hardware with proprietary deep learning algorithms to deliver cart-based image quality in portable form factors. The flagship Kosmos platform features real-time AI-driven guidance for probe positioning, automated cardiac analysis, image quality grading, and advanced Doppler capabilities (Pulsed Wave, Continuous Wave, and Tissue Doppler Imaging). Product offerings include Kosmos Portable Ultrasound, Kosmos Mobile (iPad-based), Kosmos Plus (fully featured configuration with stand), Kosmos Bladder (AI-assisted bladder volume calculation), and Kosmos EDU (educational platform for novice users). EchoNous serves critical care, emergency medicine, cardiology, nephrology, vascular access, anesthesiology, and primary care settings. The company manufactures Kosmos in the USA, offers HIPAA and SOC2 compliance, and partners with Us2.ai, 19 Labs, and Trice Imaging to deliver comprehensive software solutions and telehealth capabilities.

Wisonic Medical Technology (华声医疗) is a China-headquartered medical device company specializing in ultrasound systems and cloud-enabled clinical solutions. The company designs and manufactures specialty ultrasound platforms across multiple clinical domains: general bedside ultrasound, obstetric/gynecological ultrasound, anesthesia and pain management ultrasound, critical care ultrasound, musculoskeletal/rehabilitation ultrasound, veterinary ultrasound, and fetal monitoring systems. Primary product lines include Lotus (screening ultrasound), Polaris/Labat/Navi (anesthesia/pain), Clivia/Clover (bedside), Sunflower/Carnation (critical care), Piloter (rehabilitation), Apus (veterinary), and Lavender/Mugwort (patient monitoring/bedside monitors). The company also develops cloud-based telemedicine and remote consultation capabilities, PACS software (华声云PACS), intelligent quality control systems for ultrasound imaging, and data asset services. Wisonic holds CFDA (China FDA) approvals for multiple products and maintains ISO 13485 certification. The company operates a global distribution and service network spanning 100+ countries with presence in 3,000+ hospitals. Wisonic maintains R&D partnerships with leading universities (Tsinghua, Tongji, Michigan State) and has received national high-tech enterprise status and specialist/champion manufacturing designation from Chinese authorities. Training and clinical education are core competencies, with annual workshops and the "Dandelion Academy" cloud learning platform serving 120,000+ trained clinicians globally.

Keya Medical is an international medical technology company founded in 2016, headquartered in Beijing with offices in Seattle, Shanghai, and Shenzhen. The company specializes in deep learning-based AI solutions for non-invasive disease diagnosis and treatment, with primary focus on cardiovascular care. Keya Medical develops AI-enabled diagnostic devices that enhance efficiency, accuracy, and precision in healthcare across cardiology, neurology, pulmonology, pathology, and surgery. The flagship product, DEEPVESSEL FFR, is a CT-derived fractional flow reserve (CT-FFR) analysis software that received FDA clearance (2022), CE marking (2018), NMPA approval (2020), and HSA certification (2023). This non-invasive tool reduces unnecessary invasive testing, improves patient safety, and lowers cardiovascular diagnostic costs. The company has secured over $111.74 million in funding and holds 11 registered patents related to artificial neural networks and medical imaging. Keya Medical established the first AI diagnostic laboratory and maintains collaborations with hospitals and key opinion leaders globally.

Proprio manufactures Paradigm™, an FDA-cleared surgical navigation and AI guidance platform designed for intraoperative spinal surgery applications. Paradigm combines advanced sensors, computer vision, and light-field imaging to deliver real-time 3D anatomical visualization and measurement without ionizing radiation. The platform performs continuous segmental registration, adapting automatically as patient position, table, and surgical field change—eliminating the need for repeated intraoperative imaging. Key capabilities include on-demand radiation-free measurements of spinal alignment, disc height, and segmental angles; implant-agnostic guidance; and passive collection of structured surgical data throughout preoperative, intraoperative, and postoperative phases. Clinical data show approximately 1+ hour saved per surgery, 30% increase in reimbursements, 3-4x decrease in revision surgeries, and 10x reduction in radiation exposure. Proprio has received multiple FDA 510(k) clearances, including a third clearance for dynamic 3D segmental viewing. The platform generates standardized data enabling longitudinal learning across hospital systems, objective case documentation, training initiatives, and quality programs. Proprietary AI models, trained on cases from hundreds of surgeons, enable continuous system learning. Paradigm is designed to reduce reliance on intraoperative 3D imaging and mobile CT, potentially lowering long-term capital planning costs while optimizing surgical workflows and improving institutional surgical performance metrics.

Astute Imaging is a healthcare IT solutions company specializing in AI-powered cardiovascular imaging software for image-guided therapy and precision medicine. Founded in 2021 as a spin-off from Fivos Health, the company develops a cloud-based SaaS platform that integrates with EMR, PACS, and clinical registries. The platform automates surgery planning, device recommendations, vascular modeling and finite element analysis, and patient follow-up tracking. Astute Imaging serves healthcare providers and medical device manufacturers, supporting over 2,500 surgeons across 1,000+ centers. Key offerings include PEMS® (Patient Tracking and Management System), Preview® surgical planning tools, and proprietary finite element analysis for aortic disease management. The platform leverages 25 years of annotated vascular imaging data and AI to enhance diagnostic accuracy, provider productivity, and patient outcomes while reducing time-to-market for medical device development.